All In Biotech

Drug Trial Radar · NCT05463744

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Last checked: Nov 20, 2026Latest source record: Jun 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 692 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

692

Actual

Start

Aug 12, 2022

Primary completion

May 7, 2024

Study completion May 7, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jul 19, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes treated with multiple daily injection therapy.

Conditions

  • Type 1 Diabetes
  • Diabetes

Interventions

  • Insulin Efsitora AlfaDrug

    Administered SC

  • Insulin DegludecDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) at Week 26 [Noninferiority Analysis]Time frame: Baseline, Week 26

Locations

83 sites in 7 countries. Site status is shown where the registry gives one.

  • John Muir Physician Network Research Center

    Concord, California

  • Valley Research

    Fresno, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Sansum Diabetes Research Institute

    Santa Barbara, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Northeast Research Institute (NERI)

    Fleming Island, Florida

  • Jellinger and Lerman, MD PA dba The Center for Diabetes and Endocrine Care

    Fort Lauderdale, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Hanson Clinical Research Center

    Port Charlotte, Florida

  • East Coast Institute for Research at The Jones Center

    Macon, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Rocky Mountain Clinical Research

    Idaho Falls, Idaho

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas

  • MedStar Health Research Institute (MedStar Physician Based Research Network)

    Hyattsville, Maryland

  • Endocrine and Metabolic Consultants

    Rockville, Maryland

  • Clinvest Research LLC

    Springfield, Missouri

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • Palm Research Center Sunset

    Las Vegas, Nevada

  • Research Foundation of SUNY - University of Buffalo

    Buffalo, New York

  • NYU Langone Hospital - Long Island

    Mineola, New York

  • NYC Research

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Dallas Diabetes Research Center

    Dallas, Texas

  • North Texas Endocrine Center

    Dallas, Texas

  • Research Institute of Dallas

    Dallas, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Amir A Hassan, MD, PA

    Houston, Texas

  • Southern Endocrinology Associates

    Mesquite, Texas

  • Texas Diabetes & Endocrinology, P.A.

    Round Rock, Texas

  • Rainier Clinical Research Center

    Renton, Washington

  • Instituto Médico Especializado (IME)

    Buenos Aires, Argentina

  • Centro Diabetológico Dr. Waitman

    Córdoba, Argentina

  • Consultorio de Investigación Clínica EMO SRL

    Ciudad Autonoma de Buenos Aire, Buenos Air, Argentina

  • CIAD Moron

    Morón, Buenos Air, Argentina

  • CEDIC

    CABA, Buenos Aires, Argentina

  • Centro de Investigaciones Metabólicas (CINME)

    Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.